New drug for worldwide malaria treatment

The largest clinical trial ever conducted has concluded that the drug artesunate should now be the preferred treatment for the disease in both children and adults everywhere in the world.

Professor Nick White of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme in Bangkok, Thailand, and his colleagues conducted the trial called African Quinine v. Artesunate Malaria Trial (AQUAMAT).

http://www.ox.ac.uk/news/2010-11-08-new-drug-effective-worldwide-against-severe-malaria